Celecoxib
Information
- Drug Name
- Celecoxib
- Description
- Entry(CIViC)
CIViC
[No Data.]
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Results suggest that the response of human melanom... | APAF1 | APAF1 EXPRESSION | Resitance or Non-Reponse | true | MMMP | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05077332 | Active, not recruiting | Phase 2 | LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) | December 29, 2021 | January 2025 |
| NCT02885974 | Active, not recruiting | Phase 1 | Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer | December 2016 | September 2026 |
| NCT05256823 | Active, not recruiting | Phase 2 | Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B | February 24, 2022 | December 31, 2023 |
| NCT04041050 | Active, not recruiting | Phase 1 | A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm | November 8, 2019 | January 29, 2025 |
| NCT04786548 | Active, not recruiting | Phase 2 | Neuroinflammation in Patients With OCD | April 1, 2021 | August 2025 |
| NCT02030964 | Active, not recruiting | Phase 1 | N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan | January 16, 2014 | December 30, 2024 |
| NCT01881048 | Active, not recruiting | Early Phase 1 | Window of Opportunity Study Targeting the Inflammatory Milieu | December 8, 2009 | December 2024 |
| NCT04176419 | Active, not recruiting | Phase 3 | Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery | January 17, 2020 | October 31, 2024 |
| NCT00268476 | Active, not recruiting | Phase 2/Phase 3 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | July 8, 2005 | December 2030 |
| NCT00023621 | Completed | Phase 2 | Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome | February 2001 | July 2007 |
| NCT00023660 | Completed | Phase 1/Phase 2 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | August 2001 | |
| NCT00030407 | Completed | Phase 2 | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | October 2001 | April 2009 |
| NCT00030420 | Completed | Phase 2 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | October 2001 | February 2008 |
| NCT00032890 | Completed | Phase 3 | Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) | April 2000 | February 2004 |
| NCT00033371 | Completed | Phase 2 | Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis | December 13, 2001 | March 24, 2009 |
| NCT00036283 | Completed | Phase 2 | Chemoprevention of Oral Premalignant Lesions | November 2000 | April 2004 |
| NCT00037817 | Completed | Phase 1 | Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies | May 17, 2002 | November 9, 2009 |
| NCT00043043 | Completed | Phase 2 | Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia | May 2003 | October 2007 |
| NCT00043680 | Completed | Phase 2 | Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy | August 2002 | January 2005 |
| NCT00046839 | Completed | Phase 1/Phase 2 | Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | July 2002 | |
| NCT00047281 | Completed | Phase 2 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | March 2004 | February 2006 |
| NCT00047294 | Completed | Phase 2 | Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | April 2001 | September 2007 |
| NCT00052611 | Completed | Phase 2 | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia | June 2002 | March 2005 |
| NCT00055978 | Completed | Phase 2 | Celecoxib in Preventing Lung Cancer in Former Heavy Smokers | October 2002 | May 2009 |
| NCT00056082 | Completed | Phase 2 | Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women | January 2003 | July 2013 |
| NCT00057980 | Completed | Phase 1/Phase 2 | Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma | October 2002 | February 2007 |
| NCT00058006 | Completed | Phase 2 | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer | September 2002 | December 2006 |
| NCT00061893 | Completed | Phase 2 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | April 2004 | December 2013 |
| NCT00061906 | Completed | Phase 2 | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer | January 2003 | June 2006 |
| NCT00062101 | Completed | Phase 2 | Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer | January 2004 | |
| NCT00062179 | Completed | Phase 2 | Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | March 2003 | November 2006 |
| NCT00064181 | Completed | Phase 3 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | May 2003 | |
| NCT00065169 | Completed | N/A | Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs | November 2000 | November 2005 |
| NCT00066716 | Completed | Phase 2 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | June 2003 | |
| NCT00068432 | Completed | Phase 2 | Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer | December 2003 | July 2005 |
| NCT00068653 | Completed | Phase 2 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | June 2003 | May 2008 |
| NCT00070057 | Completed | Phase 1 | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer | April 2003 | February 2010 |
| NCT00070486 | Completed | Phase 2 | Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer | December 2003 | May 2011 |
| NCT00072072 | Completed | Phase 1 | Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | August 2003 | January 2006 |
| NCT00073866 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer | June 2003 | December 2004 |
| NCT00201773 | Completed | Phase 2 | Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | July 2003 | June 2011 |
| NCT00005094 | Completed | Phase 3 | Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps | March 2000 | |
| NCT00005878 | Completed | Phase 2 | Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus | July 2000 | September 2005 |
| NCT00006124 | Completed | Phase 2/Phase 3 | Celecoxib in Treating Patients With Bladder Cancer | June 2000 | April 2008 |
| NCT00006381 | Completed | Phase 2 | Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer | June 2000 | February 2004 |
| NCT00009230 | Completed | Phase 3 | Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial | June 2000 | August 2005 |
| NCT00014404 | Completed | Phase 2 | Celecoxib in Treating Patients With Precancerous Lesions of the Mouth | October 2000 | |
| NCT00020878 | Completed | Phase 2 | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers | March 2001 | May 2009 |
| NCT00022399 | Completed | Phase 2 | Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer | April 25, 2002 | January 31, 2005 |
| NCT00551889 | Completed | Phase 1 | Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | September 2001 | February 2012 |
| NCT00565500 | Completed | Phase 4 | Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin | April 2003 | April 2005 |
| NCT00581971 | Completed | Phase 1/Phase 2 | Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer | September 2002 | March 2012 |
| NCT00582660 | Completed | Phase 2 | Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib | December 2001 | June 2008 |
| NCT00583453 | Completed | Phase 2 | Celecoxib as a Post-tonsillectomy Pain Medication | October 2007 | May 2016 |
| NCT00596219 | Completed | N/A | Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma | December 2003 | October 2010 |
| NCT00620867 | Completed | Phase 4 | Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States) | October 2002 | March 2003 |
| NCT00630929 | Completed | Phase 4 | Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe) | January 2003 | February 2004 |
| NCT00633386 | Completed | Phase 4 | Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery | February 2003 | August 2003 |
| NCT00633438 | Completed | Phase 4 | Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery | January 2004 | June 2004 |
| NCT00638807 | Completed | Phase 4 | Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen | December 2003 | July 2004 |
| NCT00639483 | Completed | Phase 2 | Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia | March 2003 | January 2004 |
| NCT00640432 | Completed | Phase 4 | Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain | October 2003 | October 2004 |
| NCT00640627 | Completed | Phase 4 | Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen | December 2003 | September 2004 |
| NCT00640809 | Completed | Phase 4 | Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole | October 2003 | April 2004 |
| NCT00643799 | Completed | Phase 4 | Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis | March 2004 | January 2005 |
| NCT00648141 | Completed | Phase 3 | Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis | January 2003 | January 2005 |
| NCT00652925 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA | October 2002 | April 2005 |
| NCT00653250 | Completed | N/A | Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | December 2000 | January 2008 |
| NCT00662558 | Completed | Phase 3 | A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain | January 2008 | September 2008 |
| NCT00685568 | Completed | Phase 1 | Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis | November 21, 2002 | April 21, 2006 |
| NCT00686140 | Completed | N/A | A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia | June 2006 | March 2008 |
| NCT00698204 | Completed | Phase 2 | Cox-2 Inhibition in Radiation-induced Oral Mucositis | July 2003 | December 2013 |
| NCT00716547 | Completed | Phase 3 | Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA) | May 2008 | May 2009 |
| NCT00729495 | Completed | Phase 1 | Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib | July 2008 | October 2008 |
| NCT00762463 | Completed | Phase 3 | Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis | July 2009 | August 2010 |
| NCT00778193 | Completed | Phase 4 | Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers | October 2007 | March 2008 |
| NCT00807846 | Completed | Phase 4 | A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects | September 2009 | December 2012 |
| NCT00808743 | Completed | Phase 2/Phase 3 | Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis | May 2009 | January 2013 |
| NCT00882388 | Completed | Phase 4 | The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers | March 2005 | June 2005 |
| NCT00931203 | Completed | Phase 2 | Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer | July 2008 | April 2013 |
| NCT00953849 | Completed | Phase 1/Phase 2 | Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity | November 2009 | December 2015 |
| NCT00976716 | Completed | Phase 3 | An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain | September 2009 | November 2009 |
| NCT00981201 | Completed | Phase 3 | Celecoxib as a Chemopreventive Agent in Current and Former Smokers | November 2001 | September 2009 |
| NCT00994461 | Completed | Phase 4 | Study Of Celecoxib In Healthy Subjects | November 2009 | April 2010 |
| NCT01017380 | Completed | Phase 3 | Preemptive Analgesia in Cruciate Reconstruction | January 2008 | June 2009 |
| NCT01021215 | Completed | Phase 1/Phase 2 | Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers | May 2010 | March 2013 |
| NCT01062113 | Completed | Phase 2 | Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain | April 2010 | August 2010 |
| NCT01158534 | Completed | Phase 2 | Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery | March 2006 | October 2010 |
| NCT01186887 | Completed | N/A | A Trial Assessing the Outcome of Celecoxib Administration Versus Placebo Following Anterior Cruciate Ligament (ACL) Reconstruction | February 2009 | April 2013 |
| NCT01220973 | Completed | Phase 2 | Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | February 2009 | November 18, 2014 |
| NCT01280006 | Completed | Phase 1/Phase 2 | Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans | January 2011 | December 2011 |
| NCT01341405 | Completed | Phase 2 | Study of CG100649 Versus Celecoxib in Osteoarthritis Patients | April 2011 | January 2012 |
| NCT01344213 | Completed | Phase 4 | Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine | July 2008 | October 2010 |
| NCT01354145 | Completed | Phase 3 | Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI | June 2011 | October 2014 |
| NCT01425476 | Completed | Phase 1/Phase 2 | Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors | July 2008 | November 2016 |
| NCT01425853 | Completed | Phase 4 | Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis | September 2011 | May 2013 |
| NCT01449630 | Completed | Phase 1 | A Study of LY3031207 in Healthy Subjects | October 24, 2011 | April 2, 2012 |
| NCT01462435 | Completed | Phase 3 | Study of Diclofenac Capsules to Treat Pain Following Bunionectomy | October 2011 | August 2012 |
| NCT01479829 | Completed | Phase 4 | Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression | March 23, 2011 | January 24, 2018 |
| NCT01543685 | Completed | Phase 3 | Study of Indomethacin Capsules to Treat Pain Following Bunionectomy | February 2012 | July 2012 |
| NCT01549743 | Completed | Phase 1 | The Pharmacokinetic Interaction Between Celecoxib and Rebamipide | May 9, 2012 | June 13, 2012 |
| NCT01572675 | Completed | A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148) | June 2012 | March 2015 | |
| NCT01632579 | Completed | Phase 1 | A Single Dose Study of LY3023703 in Healthy Participants | June 2012 | September 2012 |
| NCT01695226 | Completed | Phase 2 | Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer | February 2004 | |
| NCT01762891 | Completed | N/A | CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen | March 2003 | September 2009 |
| NCT01765296 | Completed | Phase 3 | Phase III Study of CG100649 in Osteoarthritis Patients | March 2013 | April 2014 |
| NCT01849055 | Completed | Phase 1 | A Multiple Dose Study of LY3023703 in Healthy Participants | May 2013 | December 2013 |
| NCT01860833 | Completed | Phase 4 | NSAID Treatment in Knee Osteoarthritis | April 2010 | August 2011 |
| NCT01872910 | Completed | Phase 2 | A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal | June 2013 | October 2013 |
| NCT01876121 | Completed | Celecoxib Japan Observational Study for the Patients With Acute Pain | July 2012 | April 2013 | |
| NCT01968070 | Completed | Phase 1 | A Study of LY3127760 in Healthy Participants | October 2013 | April 2014 |
| NCT02037165 | Completed | Phase 1 | Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers | January 21, 2014 | April 15, 2014 |
| NCT02071303 | Completed | Phase 2 | Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy | May 2014 | November 2014 |
| NCT02079727 | Completed | Phase 3 | Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA | June 12, 2014 | June 16, 2016 |
| NCT02084511 | Completed | Phase 1 | Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain | March 2014 | October 2014 |
| NCT02090933 | Completed | Phase 2 | Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers | March 2004 | December 2004 |
| NCT02099136 | Completed | Phase 2 | Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers | September 1999 | December 2004 |
| NCT02108366 | Completed | Phase 3 | Treatment of Severe Influenza A Infection | March 2014 | June 2018 |
| NCT02151448 | Completed | Phase 1/Phase 2 | αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies | July 2014 | February 18, 2019 |
| NCT02179645 | Completed | Phase 1 | GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers | May 2014 | December 2014 |
| NCT02280694 | Completed | Phase 2 | Low Dose Metronomic Poly-chemotherapy for Metastatic CRC | January 2015 | December 2019 |
| NCT02343614 | Completed | Phase 2 | Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer | March 2003 | January 2014 |
| NCT02351934 | Completed | Phase 4 | Early Diuresis Following Colorectal Surgery | February 2015 | April 2016 |
| NCT02362529 | Completed | Early Phase 1 | Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder | February 2015 | April 2019 |
| NCT02401295 | Completed | Phase 1 | ATRA, Celecoxib, and Itraconazole as Maintenance | May 2015 | November 2016 |
| NCT02413203 | Completed | N/A | Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B | March 2015 | November 2015 |
| NCT02429427 | Completed | Phase 3 | European Celecoxib Trial in Primary Breast Cancer | December 2005 | March 2019 |
| NCT02484664 | Completed | Phase 2 | COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC | June 15, 2016 | November 19, 2018 |
| NCT02502500 | Completed | Phase 1 | Effect of AKB-6548 on the Pharmacokinetics of Celecoxib | July 2015 | September 2015 |
| NCT02602509 | Completed | Phase 1 | Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers | November 2015 | February 2016 |
| NCT02667730 | Completed | Phase 4 | Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries | June 2015 | December 2021 |
| NCT02688400 | Completed | Phase 3 | Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis | May 2016 | June 28, 2018 |
| NCT02703259 | Completed | Phase 4 | Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management | June 2016 | July 2017 |
| NCT02703363 | Completed | Phase 3 | Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression | August 2016 | December 2018 |
| NCT02711579 | Completed | Phase 1 | Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer | May 2016 | April 28, 2017 |
| NCT02725411 | Completed | Phase 3 | Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain | May 26, 2016 | June 11, 2019 |
| NCT02739035 | Completed | Phase 4 | MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty | April 2016 | December 2022 |
| NCT02758782 | Completed | Phase 4 | NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis | September 2016 | January 2021 |
| NCT02759198 | Completed | Phase 2 | A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis | May 2, 2016 | September 26, 2017 |
| NCT02770378 | Completed | Phase 1/Phase 2 | A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma | November 2016 | December 2020 |
| NCT02779166 | Completed | N/A | Evaluation of Perioperative Celecoxib for Hip Arthroscopy | August 2012 | May 2016 |
| NCT02850211 | Completed | Phase 4 | A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair | September 2011 | November 2015 |
| NCT02934191 | Completed | Phase 2 | Celecoxib After Tonsillectomy | June 2016 | January 31, 2019 |
| NCT02961998 | Completed | Phase 4 | Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail | July 2015 | July 2016 |
| NCT03084536 | Completed | Phase 2 | PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery | June 7, 2017 | February 25, 2021 |
| NCT03190603 | Completed | Phase 4 | Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis | June 1, 2018 | June 5, 2018 |
| NCT03304379 | Completed | Phase 3 | Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip | October 26, 2017 | November 9, 2020 |
| NCT03331315 | Completed | Phase 2 | Toradol v. Celecoxib for Postoperative Pain | September 1, 2013 | January 1, 2017 |
| NCT03403634 | Completed | Phase 2 | Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver | April 19, 2018 | August 29, 2021 |
| NCT03540030 | Completed | Phase 4 | Opioid-Free Shoulder Arthroplasty | September 2016 | June 2019 |
| NCT03570554 | Completed | Phase 2 | A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale | June 29, 2018 | June 14, 2019 |
| NCT03599453 | Completed | Early Phase 1 | Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer | January 9, 2019 | March 21, 2023 |
| NCT03818919 | Completed | Phase 2 | Nonopioid Analgesia After Rotator Cuff Repair | January 22, 2019 | December 31, 2020 |
| NCT03818932 | Completed | Phase 2/Phase 3 | Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction | January 22, 2019 | May 20, 2020 |
| NCT03820193 | Completed | Early Phase 1 | Nonopioid Analgesia After Arthroscopic Meniscus Surgery | January 22, 2019 | January 20, 2021 |
| NCT03822520 | Completed | Phase 1 | Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib | June 30, 2017 | May 25, 2018 |
| NCT03885596 | Completed | Phase 2 | Open-Label CA-008 (Vocacapsaicin) in Bunionectomy | March 25, 2019 | October 22, 2019 |
| NCT03974932 | Completed | Phase 3 | Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen | June 5, 2019 | January 7, 2021 |
| NCT04015908 | Completed | Phase 4 | A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery | August 1, 2019 | January 31, 2023 |
| NCT04081389 | Completed | Phase 1 | Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer | December 6, 2019 | February 27, 2023 |
| NCT04429022 | Completed | Phase 3 | Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy | November 24, 2020 | May 31, 2022 |
| NCT04505657 | Completed | N/A | Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography | September 1, 2020 | September 27, 2021 |
| NCT04526197 | Completed | Phase 1 | Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants. | July 7, 2020 | November 3, 2020 |
| NCT04639804 | Completed | Phase 1 | Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers | June 6, 2020 | July 29, 2020 |
| NCT04765644 | Completed | Phase 4 | Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment | June 10, 2021 | January 24, 2022 |
| NCT04790812 | Completed | Phase 4 | Preemptive Analgesia With Celecoxib for Acute Dental Pain Management | April 22, 2021 | March 1, 2023 |
| NCT05237297 | Completed | Phase 1 | Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole | February 17, 2022 | July 27, 2022 |
| NCT05324995 | Completed | Phase 2 | Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty | January 1, 2021 | March 1, 2022 |
| NCT05438303 | Completed | Phase 1 | Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers | June 13, 2022 | December 13, 2022 |
| NCT05555823 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib | June 23, 2022 | July 20, 2023 |
| NCT05994287 | Completed | N/A | Pain Treatment With Combinations of NSAIDs | January 1, 2021 | January 1, 2023 |
| NCT06004947 | Completed | Phase 1 | A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications | January 14, 2016 | June 10, 2016 |
| NCT06336993 | Completed | Phase 4 | Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP | January 1, 2022 | December 15, 2023 |
| NCT00081263 | Completed | Phase 2 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | June 2005 | |
| NCT00081848 | Completed | Phase 1 | Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors | April 20, 2004 | August 23, 2007 |
| NCT00084721 | Completed | Phase 1 | Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer | March 2005 | |
| NCT00085163 | Completed | Phase 3 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | March 2004 | |
| NCT00088959 | Completed | Phase 1 | Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | December 2003 | November 2010 |
| NCT00099047 | Completed | Phase 2 | Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma | November 2004 | November 2008 |
| NCT00101335 | Completed | Phase 2 | Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | November 2003 | January 2005 |
| NCT00104767 | Completed | Phase 1 | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | January 2009 | October 2015 |
| NCT00112502 | Completed | Phase 2 | Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme | September 2005 | September 2014 |
| NCT00136487 | Completed | Phase 2/Phase 3 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | October 2002 | September 2006 |
| NCT00137033 | Completed | Phase 4 | Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population | September 2004 | July 2005 |
| NCT00137852 | Completed | Phase 2 | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer | January 2002 | September 2017 |
| NCT00139776 | Completed | Phase 4 | Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" | July 2005 | February 2008 |
| NCT00141102 | Completed | Phase 4 | Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis | October 2005 | May 2009 |
| NCT00141154 | Completed | Phase 3 | Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan | October 2004 | |
| NCT00141193 | Completed | Phase 3 | Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) | February 2001 | May 2007 |
| NCT00152724 | Completed | Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers | January 1996 | November 2008 | |
| NCT00152828 | Completed | Phase 1/Phase 2 | Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix | February 2001 | January 2011 |
| NCT00153673 | Completed | Phase 3 | Effect of Selective COX-2 Inhibition on Ulcer Healing | February 2001 | April 12, 2017 |
| NCT00165451 | Completed | Phase 2 | A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer | June 2001 | October 2006 |
| NCT00174317 | Completed | Phase 4 | Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip | August 2003 | February 2005 |
| NCT00176813 | Completed | Phase 2 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | March 2003 | November 2006 |
| NCT00181532 | Completed | Phase 2 | Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC | May 2003 | January 2008 |
| NCT00188565 | Completed | Phase 1/Phase 2 | Celebrex With Preoperative Chemoradiation - Rectal Cancer | March 2004 | March 2009 |
| NCT00194090 | Completed | Phase 4 | Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk | June 2004 | September 1, 2005 |
| NCT00001955 | Completed | Phase 2 | Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) | December 1999 | February 2004 |
| NCT00223691 | Completed | Phase 1 | Treatment of Orthostatic Hypotension in Autonomic Failure | March 2002 | January 2017 |
| NCT00230399 | Completed | Phase 2 | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | June 2003 | March 2008 |
| NCT00258232 | Completed | Phase 2 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | January 2002 | August 2007 |
| NCT00290680 | Completed | Phase 1 | Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors | March 2005 | January 2009 |
| NCT00291694 | Completed | Phase 2 | Protocol for Women at Increased Risk of Developing Breast Cancer | April 2003 | December 2009 |
| NCT00292721 | Completed | Phase 4 | Effects of Celecoxib After Percutaneous Coronary Intervention | August 2004 | October 2008 |
| NCT00296127 | Completed | Phase 1 | Study of Celecoxib Bioavailability in Healthy Subjects | February 2006 | March 2006 |
| NCT00336960 | Completed | Phase 2 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | July 2002 | March 2008 |
| NCT00346216 | Completed | Phase 4 | Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen | October 4, 2006 | April 12, 2016 |
| NCT00346801 | Completed | Phase 1 | CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) | September 2003 | |
| NCT00355576 | Completed | Phase 2 | Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis | July 2006 | May 2007 |
| NCT00357500 | Completed | Phase 2 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | January 2005 | December 2013 |
| NCT00373685 | Completed | Phase 4 | GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) | October 2006 | November 2010 |
| NCT00400374 | Completed | Phase 1 | Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 | August 2007 | November 2016 |
| NCT00402987 | Completed | Phase 3 | Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat | December 4, 2006 | November 15, 2007 |
| NCT00446797 | Completed | Phase 4 | Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain | May 2007 | April 2008 |
| NCT00447759 | Completed | Phase 4 | The Standard Care Versus Celecoxib Outcome Trial | June 2007 | August 2015 |
| NCT00450736 | Completed | Phase 1 | Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | March 2004 | May 2009 |
| NCT00466505 | Completed | Phase 2 | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | May 2005 | November 2008 |
| NCT00471341 | Completed | Phase 4 | Effect of Celecoxib on Markers of Vascular Inflammation | July 2002 | December 2004 |
| NCT00474773 | Completed | Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery | June 2007 | December 2009 | |
| NCT00499655 | Completed | Phase 2 | Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | November 2007 | December 2016 |
| NCT00503035 | Completed | Phase 2 | Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers | August 20, 2003 | April 2, 2021 |
| NCT00520091 | Completed | Phase 2 | Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer | March 2005 | September 2010 |
| NCT00520338 | Completed | Phase 4 | Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial | August 2007 | December 2009 |
| NCT00525096 | Completed | Phase 3 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | July 2003 | December 2004 |
| NCT00538031 | Completed | Phase 2 | Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | December 22, 2003 | September 13, 2019 |
| NCT00546507 | Completed | Phase 3 | Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I | October 2007 | October 2008 |
| NCT00546832 | Completed | Phase 3 | Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial II | October 2007 | November 2008 |
| NCT00549549 | Completed | Phase 3 | Celebrex In Acute Gouty Arthritis Study | February 2008 | December 2009 |
| NCT00551005 | Completed | Phase 1 | Etoposide and Celecoxib in Patients With Advanced Cancer | December 2001 | February 2012 |
| NCT05648916 | Enrolling by invitation | Celebrex and HO Study | August 2, 2022 | August 2023 | |
| NCT06076837 | Not yet recruiting | Phase 1 | The Seven Trial: Exploiting the Unfolded Protein Response | December 2023 | December 2025 |
| NCT06340932 | Not yet recruiting | Impact of Opioid Avoidance Protocol for ACL Reconstruction | March 28, 2024 | October 1, 2024 | |
| NCT05644301 | Not yet recruiting | Phase 3 | INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder | January 2023 | September 2026 |
| NCT06328153 | Not yet recruiting | N/A | Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis | March 15, 2024 | March 1, 2026 |
| NCT05960864 | Not yet recruiting | Chinese Spondyloarthritis Inception Cohort (CESPIC) | September 2024 | August 2030 | |
| NCT05731726 | Recruiting | Phase 2 | Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer | February 22, 2023 | February 20, 2025 |
| NCT04147013 | Recruiting | Phase 4 | Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients With CRS | February 18, 2020 | April 2025 |
| NCT01356290 | Recruiting | Phase 2 | Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | April 2014 | April 2026 |
| NCT04673578 | Recruiting | Phase 2 | Adjunctive Celecoxib in Childhood-onset OCD Study | June 1, 2021 | June 2023 |
| NCT06245109 | Recruiting | Phase 4 | Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis | January 31, 2024 | August 2028 |
| NCT05488847 | Recruiting | Phase 4 | Opioid-Free Pain Protocol After Shoulder Arthroplasty | June 25, 2022 | December 1, 2025 |
| NCT06379425 | Recruiting | Phase 4 | Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries | March 1, 2024 | March 1, 2026 |
| NCT04488081 | Recruiting | Phase 2 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | July 31, 2020 | July 31, 2030 |
| NCT02574728 | Recruiting | Phase 2 | Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | June 2015 | February 2025 |
| NCT05281276 | Recruiting | Phase 1 | Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC) | September 20, 2022 | December 31, 2024 |
| NCT05756166 | Recruiting | Phase 1/Phase 2 | Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer | February 16, 2024 | June 30, 2025 |
| NCT03825809 | Recruiting | Phase 2/Phase 3 | Nonopioid Analgesia After Labral Surgery | January 22, 2019 | May 20, 2020 |
| NCT02993029 | Recruiting | N/A | 99Tc-MDP Treatment for Knee Osteoarthritis | September 1, 2017 | December 30, 2024 |
| NCT04093323 | Recruiting | Phase 2 | Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma | June 20, 2024 | August 22, 2025 |
| NCT01344200 | Recruiting | Phase 2 | CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children | January 29, 2024 | February 1, 2027 |
| NCT04469530 | Recruiting | Phase 2 | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | September 16, 2020 | September 2025 |
| NCT03912428 | Recruiting | Phase 1 | Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis | June 14, 2019 | February 22, 2030 |
| NCT00211952 | Suspended | Phase 3 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | March 2004 | |
| NCT04162873 | Suspended | Phase 2 | Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | November 27, 2019 | October 12, 2025 |
| NCT01323595 | Terminated | N/A | Effectiveness of Celecoxib After Surgical Sperm Retrieval | January 2011 | March 2013 |
| NCT00073970 | Terminated | Phase 2 | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | April 2003 | January 2006 |
| NCT00045591 | Terminated | Phase 2 | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer | February 2003 | January 2010 |
| NCT01341496 | Terminated | Phase 1 | Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal | April 18, 2011 | July 21, 2016 |
| NCT01041781 | Terminated | Phase 3 | Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer | February 2010 | March 2018 |
| NCT00080782 | Terminated | Phase 2 | Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | February 2002 | January 2005 |
| NCT00081224 | Terminated | Phase 2 | Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum | December 2004 | November 2010 |
| NCT03878524 | Terminated | Phase 1 | Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial | April 1, 2020 | December 10, 2020 |
| NCT00084448 | Terminated | Phase 2 | Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer | April 2004 | |
| NCT02502006 | Terminated | Phase 1 | Variability in Response to Non-steroidal Anti-inflammatory Drugs | November 2015 | September 2022 |
| NCT00087256 | Terminated | Phase 3 | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer | July 2004 | April 2006 |
| NCT00780325 | Terminated | Phase 1 | Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition | October 2008 | July 2013 |
| NCT00088972 | Terminated | Phase 2 | S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women | November 2004 | July 2009 |
| NCT00101062 | Terminated | Phase 2 | Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | January 2004 | December 2005 |
| NCT03949673 | Terminated | Phase 2 | Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip | April 8, 2019 | August 25, 2020 |
| NCT00894790 | Terminated | Phase 4 | Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident | November 2009 | January 2010 |
| NCT00904397 | Terminated | Phase 4 | Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain | July 2004 | |
| NCT00904605 | Terminated | Phase 4 | Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee | June 2004 | November 2004 |
| NCT00065559 | Terminated | N/A | Treatment of Diabetic Nephropathy | April 2003 | December 2004 |
| NCT00151476 | Terminated | Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients | November 2004 | November 2008 | |
| NCT00075673 | Terminated | Phase 1 | Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer | November 2003 | February 2005 |
| NCT00163241 | Terminated | Phase 3 | Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression | June 2004 | January 2006 |
| NCT02726659 | Terminated | Phase 3 | Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression | May 2016 | January 16, 2019 |
| NCT01143545 | Terminated | Phase 1 | Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas | December 7, 2010 | February 26, 2020 |
| NCT00177853 | Terminated | Phase 1 | Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer | December 2006 | July 2010 |
| NCT01284504 | Terminated | N/A | Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer | January 2011 | May 2011 |
| NCT01313429 | Terminated | Phase 1 | Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum | March 4, 2011 | February 26, 2020 |
| NCT00231829 | Terminated | Phase 2 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | April 2003 | March 2004 |
| NCT00256321 | Terminated | Phase 2 | Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma | October 2004 | August 2007 |
| NCT00305643 | Terminated | Phase 3 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | February 2006 | October 2008 |
| NCT00359151 | Terminated | Phase 4 | Celebrex Total Knee Arthroplasty Study | November 2006 | July 2007 |
| NCT02840162 | Terminated | Phase 2 | Pre-Prostatectomy Celecoxib or Placebo | May 2001 | May 2011 |
| NCT00424294 | Terminated | Phase 2 | A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis | June 2006 | February 2008 |
| NCT02845336 | Terminated | Phase 2 | Celecoxib for Thyroid Eye Disease | March 5, 2017 | June 30, 2019 |
| NCT02876094 | Terminated | Phase 2 | Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy | January 29, 2019 | August 6, 2020 |
| NCT00484718 | Terminated | Phase 4 | Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib. | January 17, 2008 | June 10, 2009 |
| NCT01632566 | Terminated | Phase 1 | A Multiple-dose Study of LY3031207 in Healthy Participants | June 2012 | April 2013 |
| NCT00068770 | Terminated | Phase 2 | Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT | October 2003 | May 2006 |
| NCT01705106 | Terminated | Phase 1 | Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies | August 29, 2012 | February 10, 2016 |
| NCT00520845 | Terminated | Phase 2 | Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer | October 2007 | January 2014 |
| NCT01729923 | Terminated | Phase 2 | A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer | March 2013 | September 6, 2016 |
| NCT00527982 | Terminated | Phase 2 | Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer | September 2005 | September 2008 |
| NCT02987920 | Terminated | Phase 4 | Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty | January 2017 | January 2018 |
| NCT00585156 | Terminated | Early Phase 1 | The Effects of Celecoxib on Bone Ingrowth | June 2008 | September 2008 |
| NCT00585312 | Terminated | Phase 3 | Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) | September 2006 | October 2013 |
| NCT02054104 | Terminated | Phase 1/Phase 2 | Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum | September 3, 2014 | June 15, 2015 |
| NCT00608595 | Terminated | N/A | Celecoxib in Treating Patients With Early-Stage Rectal Cancer | July 2002 | April 2008 |
| NCT00037180 | Terminated | Phase 2 | For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy | April 2002 | January 2003 |
| NCT03473665 | Terminated | Phase 4 | Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis | March 1, 2018 | August 2, 2019 |
| NCT02192190 | Terminated | Phase 2 | A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain | July 2014 | June 2015 |
| NCT05077969 | Terminated | Phase 2 | Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) | December 29, 2021 | July 8, 2022 |
| NCT00665457 | Terminated | Phase 2 | Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | April 15, 2004 | July 31, 2009 |
| NCT00688545 | Terminated | Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis | April 2009 | January 2012 | |
| NCT02408146 | Unknown status | N/A | The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection | January 2014 | |
| NCT00500279 | Unknown status | Phase 4 | Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial | November 2006 | October 2009 |
| NCT03404479 | Unknown status | Phase 4 | Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA | January 25, 2018 | January 2, 2019 |
| NCT02739204 | Unknown status | Phase 2 | Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma | November 2013 | December 2017 |
| NCT00300729 | Unknown status | Phase 3 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy | May 2006 | September 2010 |
| NCT00274898 | Unknown status | Phase 2 | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | May 2004 | |
| NCT00218205 | Unknown status | Phase 2 | A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer | July 2002 | June 2006 |
| NCT00215345 | Unknown status | Phase 2 | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | August 2002 | December 2006 |
| NCT02790203 | Unknown status | N/A | Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain | June 2016 | |
| NCT02827487 | Unknown status | Phase 4 | Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion | July 1, 2016 | July 1, 2020 |
| NCT00357617 | Unknown status | Phase 1/Phase 2 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | June 2006 | |
| NCT00597415 | Unknown status | Phase 2 | Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee | December 2004 | March 2008 |
| NCT00603759 | Unknown status | Phase 3 | COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma | April 2006 | August 2009 |
| NCT01503385 | Unknown status | Phase 2 | Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC) | December 2011 | December 2016 |
| NCT03305068 | Unknown status | Phase 4 | Evaluation of Post-Procedure Administration of Celecoxib Following Shoulder Surgery | February 2014 | June 2018 |
| NCT04490434 | Unknown status | Phase 1 | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs | June 19, 2020 | November 30, 2020 |
| NCT01583660 | Unknown status | Clinical Research of the Prognostic Influence of NSAIDS's Anti-inflammatory Effect on Senior Patients With Hip Fracture | January 2012 | December 2015 | |
| NCT01623921 | Unknown status | N/A | Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma | August 2012 | August 2013 |
| NCT01631669 | Unknown status | N/A | Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification | May 2012 | June 2018 |
| NCT03337607 | Unknown status | N/A | Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain | November 13, 2017 | October 2019 |
| NCT04997174 | Unknown status | Comparison of Postoperative Pain Management in Patients Undergoing Laparoscopic Colorectal Surgery Under Enhanced Recovery After Surgery (ERAS) Program, Laparoscopic Colorectal Surgery Without ERAS and Open Colorectal Surgery | October 2021 | December 2022 | |
| NCT00533247 | Unknown status | N/A | Arthroplasty Inflammation Prophylaxis With Celecoxib | ||
| NCT02736071 | Unknown status | Phase 3 | Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy | June 2016 | |
| NCT02537925 | Unknown status | Phase 3 | The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma | January 2014 | December 2016 |
| NCT02736019 | Unknown status | Phase 3 | Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women | June 2016 | |
| NCT01150045 | Unknown status | Phase 3 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | June 2010 | |
| NCT00072553 | Unknown status | Phase 2 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | September 2003 | |
| NCT02638896 | Unknown status | Phase 4 | Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis | January 2016 | April 2017 |
| NCT00589186 | Unknown status | Phase 2 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | November 2007 | |
| NCT00295035 | Unknown status | Phase 3 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer | March 2006 | March 2007 |
| NCT00084578 | Withdrawn | N/A | Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder | March 2004 | April 2006 |
| NCT05085574 | Withdrawn | Phase 2 | Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1) | February 7, 2023 | February 7, 2023 |
| NCT02160301 | Withdrawn | Phase 4 | Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients | November 2017 | December 2019 |
| NCT00027976 | Withdrawn | Phase 2/Phase 3 | Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses | December 2001 | December 2005 |
| NCT00084370 | Withdrawn | N/A | Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | June 2002 | March 2005 |
| NCT00025051 | Withdrawn | Phase 2 | Celecoxib in Preventing Skin Cancer | ||
| NCT00293436 | Withdrawn | Phase 1/Phase 2 | Celecoxib and Erlotinib in Treating Patients With Liver Cancer | January 2005 | |
| NCT02839694 | Withdrawn | Phase 1 | Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy | July 7, 2016 | April 26, 2017 |
| NCT00304317 | Withdrawn | Phase 4 | Celecoxib (Celebrex) in the Management of Acute Renal Colic | March 2006 | August 2008 |
| NCT03121963 | Withdrawn | Phase 4 | Pain Management in Head and Neck Surgery Patients | November 10, 2017 | November 6, 2021 |
| NCT03185871 | Withdrawn | Phase 2 | Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses | September 20, 2017 | October 10, 2018 |
| NCT00093678 | Withdrawn | N/A | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer | ||
| NCT00442676 | Withdrawn | Phase 2 | Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia | June 2009 | January 2010 |
| NCT00072540 | Withdrawn | Phase 2 | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix | ||
| NCT00108186 | Withdrawn | Phase 1 | Celecoxib Treatment for Lung Cancer | October 2004 | June 2011 |
| NCT00687388 | Withdrawn | Phase 4 | The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia | May 2008 |
- Target (Drug list of Screening Committee of Anticancer Drugs)
- Cyclooxygenase-2 (COX-2)